Source: Eur Respir Rev 2015; 24: 52-57



Rating:

Share or cite this content

Citations should be made in the following way:
McElvaney Noel G.. Diagnosing alpha 1-antitrypsin deficiency: how to improve the current algorithm. Eur Respir Rev 2015; 24: 52-57

Member's Comments

No comment yet.

Related content which might interest you: COVID-19 infection in Severe Alpha 1-antitrypsin deficiency: looking for a rationale Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19 Year: 2021 Targeted screening programmes in COPD: how to identify individuals with alpha 1-antitrypsin deficiency Source: Eur Respir Rev 2015; 24: 40-45 Year: 2015 Clinical features of alpha one antitrypsin deficiency in COPD Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Phase I safety investigation of an aerosolized, recombinant alpha 1-antitrypsin in subjects with alpha 1-antitrypsin deficiency Source: Eur Respir J 2004; 24: Suppl. 48, 228s Year: 2004 Alpha 1 - antitrypsin deficiency: diagnosis and treatment Source: Virtual Congress 2021 – Alpha 1 - antitrypsin deficiency: diagnosis and treatment Year: 2021 Alpha 1-antitrypsin deficiency Source: Breathe 2008; 4: 377-380 Year: 2008 A case report of alpha 1-antitrypsin deficiency in a six-month infant Source: Eur Respir J 2004; 24: Suppl. 48, 228s Year: 2004 Reduction in incidence of exacerbations in patients with alpha 1 antitrypsin deficiency (A1ATD) treated with concentrates of alpha 1 antitrypsin (A1AT): REXA study Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Long-term experience in the treatment of alpha 1-antitrypsin deficiency: 25 years of augmentation therapy Source: Eur Respir Rev 2015; 24: 46-51 Year: 2015 Expanding the awareness of Alpha-1 antitrypsin deficiency (AATD) to provide a multidisciplinary approach to care Source: Virtual Congress 2020 – Airway diseases Year: 2020 Has cardiopulmonary exercise testing a role in detecting early emphysema in alpha 1-antitrypsin deficiency? Source: Eur Respir J 2001; 18: Suppl. 33, 84s Year: 2001 Diagnosing alpha-1 antitrypsin deficiency in Romania - first 1000 cases tested Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement? Year: 2020 Implementation of screening program for alpha-1 antitrypsin deficiency in Spain Source: Annual Congress 2004 - Emphysema and oxygen therapy Year: 2004 The patient perspective of alpha-1 antitrypsin deficiency: disease burden and unmet needs Source: Breathe, 17 (1) 200340; 10.1183/20734735.0340-2020 Year: 2021 Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits Source: Eur Respir J, 50 (3) 1700198; 10.1183/13993003.00198-2017 Year: 2017 Decline in health status in alpha1 antitrypsin deficiency Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 Diagnosis of alpha 1 antitrypsin deficiency in primary care Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care Year: 2015 Alpha-1 antitrypsin deficiency severity and the risk of COVID-19 Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19 Year: 2021 Clinical and functional characteristics of Italian and Spanish patients with alpha 1-antitrypsin deficiency Source: Annual Congress 2012 - COPD: epidemiology and varia Year: 2012